Creatine, Healing, and Why I Don’t Use It When Teaching People to Recover From Frailty

© Courtney Hunt, MD, 2026

Creatine is one of the most studied supplements in human physiology, and it is often presented as universally beneficial for muscle, brain, and aging. That framing is incomplete. Creatine is not a growth signal. It is a buffer. Whether that buffer helps or harms depends entirely on the biological state of the person using it and the goal of the intervention.

When I am teaching people to heal from frailty, sarcopenia, menopausal decline, or early neurodegenerative patterns, I do not use creatine at the start. Not because creatine is bad, but because buffering energy before adaptation has been restored interferes with the very signals required for healing.

Simply stated: Creatine protects performance, but healing requires adaptation first.

What creatine actually does in the body

Creatine increases short-term ATP availability by donating phosphate through the phosphocreatine system. This reduces the fall in ATP during exertion, lowers the rise in AMP, and decreases reliance on mitochondrial ATP production in the moment. From a biochemical perspective, creatine reduces energetic strain.

This is why creatine improves strength, sprint output, and fatigue resistance. It allows muscle to maintain force without requiring the mitochondria to fully meet demand in real time.

Simply stated: Creatine makes hard work feel easier at the cellular level.

Why that matters for healing

Adaptation occurs when cells detect energetic stress. A rising AMP/ATP ratio activates AMPK, which in turn drives mitochondrial biogenesis, autophagy, metabolic flexibility, and endocrine signaling from muscle to brain. This stress response is not pathological; it is how tissues learn to upgrade.

Creatine blunts this signal. By buffering ATP demand, it reduces AMPK activation, dampens downstream PGC-1α signaling, and lowers lactate production. In someone whose problem is loss of reserve, this matters.

Simply stated: If the stress signal is softened, the body has less reason to rebuild.

Frailty, sarcopenia, and the buffering trap

Frailty and sarcopenia are often treated as deficiencies of protein or calories, but biologically they reflect loss of adaptive reserve. Muscle no longer responds robustly to stress. Mitochondria downshift. Recovery becomes slow and incomplete.

In this context, adding creatine too early stabilizes a weakened system. Muscle output may improve temporarily, but the underlying signaling deficit remains. Strength without adaptation is brittle.

This is why people can look stronger while continuing to decline metabolically.

Simply stated: Buffering weakness doesn’t fix it; it preserves it.

Menopause and the loss of metabolic margin

Menopause removes hormonal buffering that previously masked poor metabolic signaling. Insulin sensitivity declines, muscle mass drops, mitochondrial efficiency worsens, and neurotrophic signaling decreases. This is why sarcopenia, cognitive changes, and fatigue often accelerate together.

What is needed here is restoration of AMPK-driven adaptation and muscle-derived endocrine signaling, including lactate-mediated BDNF upregulation. Creatine interferes with that process when introduced too early by dampening the energetic signals that force adaptation.

Simply stated: Menopause exposes the need for adaptation, not more buffering.

Neurodegeneration and the muscle–brain signal

Skeletal muscle is an endocrine organ. During true energetic strain, muscle produces lactate and myokines that cross the blood–brain barrier and stimulate BDNF, supporting synaptic plasticity and neurogenesis. This muscle–brain signaling axis weakens with age, inactivity, and sarcopenia.

Creatine reduces lactate signaling by lowering reliance on glycolytic and oxidative stress pathways. While creatine can be neuroprotective in injury or disease states, it does not stimulate neurogenesis. That requires effort-induced signaling.

Simply stated: Brain growth comes from muscle effort, not energy buffering.

Why I don’t use creatine when teaching people to heal

When the goal is healing rather than performance, the priority is restoring the body’s ability to sense stress and respond appropriately. That requires allowing ATP to fall, AMP to rise, AMPK to activate, and downstream signaling to occur. Creatine interrupts this sequence.

Once adaptive reserve has been rebuilt—once muscle, mitochondria, and brain signaling are robust again—creatine can be used strategically to protect gains, reduce injury risk, or support recovery during extreme stress. It does not belong at the front end of a healing protocol.

Simply stated: You don’t buffer a system that hasn’t relearned how to adapt.

How HFFF fits into this

HFFF (HUNT: HIIT, Fast, stay Fat-adapted, then Feast to Fix) is the framework I use to restore adaptive signaling before any buffering tools are introduced. HIIT raises AMP and lactate. Fasting preserves AMPK activation. Staying fat-adapted forces mitochondrial remodeling. Feasting then converts signal into structure.

Creatine works against the early phases of this sequence. That is why it is deliberately excluded when the goal is recovery from frailty, sarcopenia, menopausal decline, or early neurodegeneration.

Simply stated: HFFF rebuilds capacity; creatine is for after capacity exists.

The bottom line

Creatine is not a healing agent. It is a performance buffer. Used at the wrong time, it interferes with the very signals that reverse frailty, rebuild muscle, and support brain resilience. Used at the right time, it can protect what has already been rebuilt.

When I teach people to heal, I teach them to restore adaptation first.That is why I do not use creatine at the beginning.

© Courtney Hunt, MD, 2026